Company / Free Cash Flow
Olema Pharmaceuticals, Inc. Free Cash Flow History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$104.5M
FY2024
5-year range
-$104.5M / -$19.9M
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#109 of 194
Health Care
What the data says
At -$105M, Olema Pharmaceuticals, Inc.'s free cash flow ranks #109 of 194 in the Health Care sector. Free Cash Flow has declined for 3 consecutive years, from -$20M in FY2020 to -$105M in FY2024.
Based on SEC 10-K filings.
-$105M in FY2024.
Declined from -$52M to -$105M over the past 3 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 194 in Health CareTop 56% of 194This company -$104.5M Sector average $470.6M
▼
-122.2% below sector average
Key checks
Key Insights
- Ranks #109 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$104.5M | - |
| FY2023 | - | - |
| FY2022 | -$82.4M | -57.7% |
| FY2021 | -$52.3M | -162.3% |
| FY2020 | -$19.9M | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026